Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone-nanoparticles

World Journal of Gastroenterology

Volumn 5, Issue 6, 1999, Pages 511-514

  Zhang, Zhi Rong ^a,b,c,d,e   He, Qin ^a   Liao, Gong Tie ^a   Bai, Shao Huai ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Chinese Pharmacopoeia Commission   (China)

^d Chinese Pharmaceutical Association (CPA)   (China)

^e Society of Pharmaceutics of CPA   (China)

Author keywords

Mitoxantrone nanospheres toxicity; Neoplasm transplantation; Nude mice

Indexed keywords

EID: 0000819406     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i6.511     Document Type: Article

References (4)

1. Gu GW, Lu SZ. Hepatocarcinoma pathological epidemiology. Foreign Med Sci - Physiol, Pathol Clin Fascicle, 1991;11:91-93
2. Ma YP, Zheng S. The anticancer drug mitoxantrone. World Phamr - Synthet Drug, Biochem Drug Pharmac Fascicle, 1986;7:324 -327
3. Couvreur P, Kante B, Roland M, Guito P, Bauduin P, Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol, 1979;31:331-336
4. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/ cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol, 1989;134:733-739